SCHEMBL11355290

SCHEMBL11355290

O=C1NC(=O)C2(CCOc3ccc(Cl)cc32)O1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ AKR1B10 O60218 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ AKR1A1 P14550 1/20 0.39
▸ AKR1B1 P15121 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11372831 0.83 AKR1B1 (0.58) AKR1B10MAPTAKR1A1AKR1B1
SCHEMBL11353054 0.83 AKR1B10 (0.39) AKR1B10MAPTAKR1A1AKR1B1
SCHEMBL11367422 0.80 LDHA (0.37) —
SCHEMBL11472424 0.78 KDM1A (0.42) —
SCHEMBL11351100 0.78 AKR1B1 (0.35) AKR1B1
SCHEMBL11377797 0.76 AKR1B1 (0.36) AKR1B1
SCHEMBL17606651 0.75 LMNA (0.37) MAPT
SCHEMBL11352954 0.74 VHL (0.39) —
SCHEMBL10921763 0.73 AKR1B1 (0.71) AKR1B10MAPTAKR1A1AKR1B1
SCHEMBL10923913 0.73 AKR1B1 (0.71) AKR1B10MAPTAKR1A1AKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4305877-A ALDOSE REDUCTASE ENZYME INHIBITOR FOR TREATMENT OF CHRONIC DIABETIC COMPLICATIONS PFIZER INC. (US) 1981-12-15 — — US disclosed
US-4267342-A INHIBITORS OF OXIDOREDUCTASE ENZYMES; NERVOUS SYSTEM DISORDERS AND VISION DEFECTS CAUSED BY DIABETES PFIZER INC. (US) 1981-05-12 — — US disclosed
US-4200642-A ENZYME INHIBITORS PFIZER INC. (US) 1980-04-29 — — US disclosed
Send feedback